Authors
Latest:
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating SymptomsHyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
COPD Increases Risk for Heart Failure in People who Experience AMI“Patients with COPD who have AMI are less aggressively treated than those without COPD," leading to higher in-hospital mortality and long-term mortality,” wrote authors.
Latest:
With the Flu Season in Overdrive, Hospitals are OverwhelmedSome hospitals have EDs filled with patients and a number of states are reporting the 2024-2025 version of a COVID-19, flu, and RSV tripledemic.
Latest:
Obesity-related Comorbidities and Treatment: An OverviewAn overview of common and uncommon obesity-related comorbidities and treatment strategies, here.
Latest:
3 Ways Physicians Can Support Patients with Obesity in 2023Three tips on how to support patients on their weight management journey this year.
Latest:
Obesity and Depression in Adolescents: Understanding the InterplayUnderstanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.
Latest:
Long Colds: How to Manage Patient Expectation About Duration of the Common ColdPatients largely underestimate how long a cold should last and the lingering symptoms too often prompt a request for antibiotics. Primary care, please resist!
Latest:
Final Thoughts on Strategies for Managing and Monitoring Patients Receiving TeplizumabThe panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
Latest:
Symbravo Mechanism of Action and Patient Selection, with PI Stewart Tepper, MDTepper, principal investigator for phase 3 trials of Symbravo as acute treatment for migraine in adults, reviews the new drug's dual MOA and target patient populations.
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Switching from HRT to Non-HRT: Safety Considerations for Menopausal WomenAn expert discussion with JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program of elinzanetant for moderate-to-severe VMS.
Latest:
Budesonide-Based Triple Therapy Most Cost-Effective vs Dual Therapy for COPDA new analysis found triple therapy for COPD, particularly B/G/F, more cost-effective vs dual therapy in terms of exacerbations and quality-adjusted life years.
Latest:
5 Elemental Facts About Electronic Cigarettes All Clinicians Should KnowThe 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.
Latest:
When the Patient Says Pain is the Problem, Physiatry Has a PlanThe goal of a PM&R physician is to identify the source of function-limiting pain and then develop the best plan for each patient to return them to their lives.
Latest:
Breaking the Silence: Discussing Menopause Treatment Options in Primary CareLisa Larkin, MD, discusses how social media is driving menopause awareness and why primary care physicians must educate themselves to meet patient demand.
Latest:
Key Insights and Final Thoughts on Screening and Management of T1DPanelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
Mifepristone Future Uncertain, Pushback is United and SwiftThe FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.
Latest:
Axsome Therapeutics: FDA Accepts NDA Resubmission for AXS-07 for Acute Treatment of MigraineBased on its acceptance of the resubmission, FDA has assigned a PDUFA action goal date of January 31, 2025 for AXS-07.
Latest:
Stress Management 2021: The Case for Self-Care in the COVID-19 EraObesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.
Latest:
Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 TrialFindings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.
Latest:
GoodRx, Opill Team Up on OTC Delivery Program for ContraceptiveThe new e-commerce partnership expands access to Opill by allowing direct delivery of the contraceptive to consumers' homes without a prescription.
Latest:
American Academy of Pediatrics Counters CDC with Updated Childhood Immunization ScheduleIn its updated guidelines, the AAP recommends that all children aged 6 to 23 months be vaccinated against COVID-19, citing the population's high risk for severe infection.
Latest:
Key Insights and Final Thoughts on Screening and Management of T1DPanelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Latest:
Atopic Dermatitis in Focus: 3 Expert Pearls for Primary CareRAD 2025: Expert insights on the psychosocial burden of AD, flexible dosing, and cross-specialty collaboration in pediatric care.
Latest:
The Future of Multi-Cancer Early DetectionTo close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.
